Biological PCR Technology Market to Grow at CAGR of 7.36% through 2030
Advancements in
PCR technology and rising prevalence of infectious diseases are expected to
drive the Global Biological PCR Technology Market growth in the forecast
period, 2026-2030.
According to
TechSci Research report, “Biological PCR Technology Market – Global Industry
Size, Share, Trends, Competition, Forecast & Opportunities, 2020-2030F”,
the Global Biological PCR Technology Market stood at USD 13.12 Billion in 2024 and is
expected to reach USD 20.14 Billion by 2030 with a CAGR of 7.36% during the
forecast period.
The global
Biological PCR (Polymerase Chain Reaction) Technology Market is experiencing
significant growth driven by advancements in molecular diagnostics, research,
and genetic testing. PCR technology, which revolutionized molecular biology by
enabling the amplification and detection of specific DNA or RNA sequences, is
increasingly applied in a wide range of fields such as clinical diagnostics,
oncology, genetics, infectious disease detection, and personalized medicine.
This market has gained remarkable traction over the years due to its high
sensitivity, accuracy, and versatility, making it a key technology in both
research and clinical settings.
The demand for
PCR technology is particularly high in the healthcare sector, where it plays a
pivotal role in diagnosing infectious diseases, detecting genetic disorders,
and identifying cancer biomarkers. The increasing prevalence of chronic
diseases such as cancer, diabetes, and genetic disorders, coupled with the rise
in infectious diseases globally, has amplified the need for reliable diagnostic
methods like PCR. PCR is extensively used for detecting viruses like HIV,
hepatitis, tuberculosis, and, most recently, COVID-19, which drove an
unprecedented surge in PCR testing. The ongoing COVID-19 pandemic underscored
the importance of PCR technology in diagnostic testing, highlighting its ability
to provide fast, accurate, and reliable results, which have been vital in
controlling outbreaks and providing timely medical intervention.
As the demand
for PCR testing continues to grow, there is a corresponding surge in the need
for PCR reagents, consumables, and instrumentation. PCR reagents, which include
primers, enzymes, nucleotides, and buffers, are essential for the efficient
functioning of the PCR reaction. The increased volume of testing has
significantly driven the sales of these reagents, with market players focusing
on developing high-quality, cost-effective, and specialized reagents to meet
the diverse needs of diagnostics, research, and clinical applications. In
parallel, PCR instruments such as thermal cyclers, real-time PCR machines, and
multiplex PCR systems are continuously evolving to offer faster, more accurate,
and automated solutions for a variety of PCR applications.
The integration
of PCR technology into personalized medicine is another major driver of market
growth. Personalized medicine involves tailoring treatment plans based on
individual genetic profiles, and PCR plays a central role in identifying
genetic mutations and variations in patients. In oncology, PCR is used to
detect specific cancer-related mutations and assess tumor characteristics,
enabling clinicians to choose the most appropriate treatment options for
patients. Similarly, PCR-based genetic tests are used to identify carriers of
hereditary diseases, enabling early intervention and preventive healthcare
measures. The growing focus on personalized treatment has led to increased
demand for PCR technology, which is crucial for analyzing genetic information
and optimizing therapy choices.
Another factor
contributing to the growth of the Biological PCR Technology Market is the
expanding application of PCR in research. Researchers in fields like genomics,
microbiology, and environmental science rely on PCR to conduct a wide range of
studies, including gene expression analysis, pathogen detection, and gene
sequencing. The advent of next-generation sequencing (NGS) technologies has
further propelled the use of PCR, as it is often used in combination with
sequencing techniques to identify and analyze genetic variations and mutations.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Biological PCR Technology Market”
The Global Biological
PCR Technology Market is segmented into product type, end use, regional
distribution, and company.
Based on product
type, the consumables such as PCR tubes, plates, pipette tips, and other
labware are necessary to facilitate the testing process but are used less
frequently than reagents. While consumables play a critical role in ensuring
the smooth operation of PCR tests, they do not have the same level of impact on
the quality of results as reagents do. Consumables are typically replenished
periodically, but their consumption rate is often lower in comparison to
reagents. PCR systems and their associated reagents generally determine the
overall performance of PCR tests, and as a result, the reagent market is more
expansive and influential.
The growing
demand for high-throughput PCR testing and the push for automation also
contribute to the dominance of reagents in the market. High-throughput systems,
which are used for large-scale screening, require large quantities of reagents
to process multiple samples simultaneously. This is particularly evident in
research settings and clinical diagnostics, where PCR is often used for
large-scale genetic testing, viral load quantification, and pathogen
identification. The increasing focus on early disease detection, personalized
medicine, and rapid diagnostics further fuels the demand for reagents, driving
their market growth.
Based on region,
Europe is the second-largest player in the global Biological PCR
Technology Market, following North America in terms of market dominance. Europe
has seen significant adoption of PCR technology, primarily driven by the
growing demand for molecular diagnostics, advanced healthcare infrastructure,
and increasing investments in research and development. The region's strong
healthcare systems, well-established regulatory frameworks, and a growing
emphasis on early disease detection, personalized medicine, and genetic research
have all contributed to the expansion of PCR technology applications. In
Europe, PCR technology is widely used in clinical diagnostics, including the
detection of infectious diseases, genetic disorders, and cancer biomarkers. The
rising prevalence of chronic diseases such as cancer, diabetes, and genetic
conditions has prompted healthcare providers to rely on more accurate and rapid
diagnostic methods like PCR. The ability of PCR to provide quick and precise
results in detecting pathogens, identifying mutations, and screening for
diseases has made it indispensable in medical practice. The growing focus on
preventive healthcare and personalized medicine is further enhancing the demand
for PCR-based testing, as it allows for tailored treatments and earlier
interventions.
Europe's strong
emphasis on research and innovation plays a pivotal role in the growth of the
PCR market. The region is home to a multitude of academic and research
institutions that heavily invest in genetic research, biotechnology, and
clinical diagnostics. PCR technology is a cornerstone in genomics and molecular
biology research, and its applications extend to a wide array of studies,
including gene expression analysis, pathogen detection, and next-generation
sequencing (NGS). As research in genetics and personalized medicine continues
to advance, the demand for PCR technology in research laboratories is expected
to rise, further strengthening Europe's position in the global market. Regulatory
support in Europe, particularly from organizations such as the European
Medicines Agency (EMA), the European Commission, and national regulatory
bodies, also contributes to the widespread adoption of PCR technology. These
agencies play an essential role in ensuring the safety, efficacy, and quality
of PCR-based diagnostic products. The approval processes for PCR testing
devices and reagents in Europe are stringent, ensuring that only high-quality
products reach the market. This regulatory environment fosters innovation while
maintaining high standards for patient care, which boosts the confidence of
healthcare providers in the use of PCR technology.
Major companies
operating in Global Biological PCR Technology Market are:
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN GmbH
- Takara Bio Inc.
- Merck KGaA
- Bioneer Corporation
- Illumina, Inc.
- Promega Corporation
- Eppendorf SE
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The future of
the global Biological PCR Technology Market looks promising, driven by ongoing
advancements in molecular diagnostics, personalized medicine, and genetic
research. The increasing prevalence of chronic diseases, infectious outbreaks,
and a growing demand for precise, rapid diagnostic methods will continue to
propel the market forward. Key innovations, such as digital PCR and multiplex
PCR, promise enhanced sensitivity, accuracy, and throughput, making PCR
technology even more indispensable in clinical and research applications. The
integration of automation and artificial intelligence (AI) into PCR systems
will improve efficiency and reduce human error. As personalized medicine and
early disease detection become central to healthcare, the market will see
continued expansion, with increasing investments in PCR technology across the
globe”, said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“Biological PCR Technology Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type
(Reagents and Consumables), By End Use (Diagnostic Laboratories and Molecular
Testing Laboratories), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Biological PCR Technology Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Biological PCR Technology Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com